mdm2 gene mediates the expression of mdrl gene and P-glycoprotein in a human glioblastoma cell line
1996

mdm2 Gene and Multidrug Resistance in Glioblastoma Cells

publication Evidence: moderate

Author Information

Author(s): S Kondol, Y Kondo, H Hara, R Kaakaji, JW Peterson, T Morimura, J Takeuchi, GH Barnett

Primary Institution: The Cleveland Clinic Foundation

Hypothesis

Does the mdm2 gene induce the expression of the mdrl gene and P-glycoprotein in human glioblastoma cells?

Conclusion

The mdm2 gene induces the expression of the mdrl gene and P-glycoprotein, leading to resistance against chemotherapy in glioblastoma cells.

Supporting Evidence

  • The mdm2 gene was shown to induce the expression of the mdrl gene and P-glycoprotein in U87-MG cells.
  • MDM2-U87-MG cells exhibited significant resistance to the chemotherapy drugs VP-16 and doxorubicin.
  • Transfection with mdm2 resulted in the overexpression of MDM2 protein and P-glycoprotein.

Takeaway

The mdm2 gene helps cancer cells resist treatment by making them produce a protein that pumps out the medicine, making it less effective.

Methodology

Human glioblastoma U87-MG cells were transfected with the mdm2 gene, and the effects on mdrl and P-glycoprotein expression were assessed using various assays.

Limitations

The study does not assess the stability of increased mdm2 and P-gp expression in transfectant sublines.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication